Compounds such as IBU-PO, which mimic the activation of the Wnt signaling pathway, could eventually rescue neurons from cytotoxicity through GSK-3β inhibition, which may be of potential benefit for the treatment of AD patients. The gene discussed is GSK3B; the disease is Alzheimer disease.